W 906 (Ranitidine 150 mg)
Pill imprint W 906 has been identified as Ranitidine hydrochloride 150 mg.
Ranitidine is used in the treatment of gerd; erosive esophagitis; gastric ulcer maintenance treatment; duodenal ulcer; eczema (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 150 mg
- 11.00 mm
- Rx and/or OTC
silicon dioxide colloidal
|NDC Code||Manufacturer / Repackager|
|63304-0838||Ranbaxy Pharmaceuticals Inc.|
|54569-4507||A-S Medication Solutions, LLC (repackager)|
|68115-0314||Dispensexpress Inc (repackager)|
|58016-0345||Southwood Pharmaceuticals Inc (repackager)|
|33261-0099||Aidarex Pharmacuticals, LLC (repackager)|
|67544-0483||Prepak Systems Inc (repackager)|
Note: Inactive ingredients may vary.
More about ranitidine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.